Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Manitoba

$25,000.00

Scheduled usage optimization of Sunnex light and eyewear technologies to avoid jet lag

FY 2011-12

Summary
Sunnex Biotechnologies is a 36 year old Canadian company that has been involved in development of low-intensity Lo-LIGHT therapy lamp with application on circadian rhythm for the past 16 years. Studies conducted with the Lo-LIGHT for the National Space Biomedical Research Institute by Harvard University and laboratory trials by DRDC and the USAF have indicated that Sunnex Biotechnologies low intensity light technology would be effective in a protocol for negating the effects of jet lag. However, despite several studies suggesting protocols for designing interventions that facilitate re-entrainment to a shifted sleep-wake schedule, there is yet no optimum scheduled light therapy protocol. Hence, it is of great importance for Sunnex Biotechnologies to determine an optimum algorithm for effective application of the Lo-LIGHT technology. This proposal establishes the first collaborative relationship between Dr. Moussavi (the PI) and Sunnex Biotechnologies. The results of this short-term proposal will have a significant impact on the future direction of the company and opens up an avenue for licensing and developing a product in the very applicable area of trans-meridian travelling. The objective of this project is to develop an algorithm that provides the optimal timing schedule for: 1) exposure to a specific range and intensity of visible-light wavelengths, and 2) usage of specialized eyewear which limits the transmission of wavelengths to the eye. The application of such optimum protocol would be to realigning the circadian rhythms of a trans-meridian traveller from the point of departure to the destination in a safe, practical and convenient manner. Over a million people per month take trans-oceanic flights from Canada to overseas countries and vice versa. The development of an optimized light therapy schedule algorithm for use of Sunnex Biotechnologies' Lo-LIGHT lamp would effectively addresses the widespread circadian rhythm problems that has no practical solution at this time.
Program
Engage Grants Program
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
428528-2011
Name nom
KazemMoussavi, Zahra
Department département
Electrical and Computer Engineering
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Scheduled usage optimization of Sunnex light and eyewear technologies to avoid jet lag
Keyword
NSERC
Application summary
Sunnex Biotechnologies is a 36 year old Canadian company that has been involved in development of low-intensity Lo-LIGHT therapy lamp with application on circadian rhythm for the past 16 years. Studies conducted with the Lo-LIGHT for the National Space Biomedical Research Institute by Harvard University and laboratory trials by DRDC and the USAF have indicated that Sunnex Biotechnologies low intensity light technology would be effective in a protocol for negating the effects of jet lag. However, despite several studies suggesting protocols for designing interventions that facilitate re-entrainment to a shifted sleep-wake schedule, there is yet no optimum scheduled light therapy protocol. Hence, it is of great importance for Sunnex Biotechnologies to determine an optimum algorithm for effective application of the Lo-LIGHT technology. This proposal establishes the first collaborative relationship between Dr. Moussavi (the PI) and Sunnex Biotechnologies. The results of this short-term proposal will have a significant impact on the future direction of the company and opens up an avenue for licensing and developing a product in the very applicable area of trans-meridian travelling. The objective of this project is to develop an algorithm that provides the optimal timing schedule for: 1) exposure to a specific range and intensity of visible-light wavelengths, and 2) usage of specialized eyewear which limits the transmission of wavelengths to the eye. The application of such optimum protocol would be to realigning the circadian rhythms of a trans-meridian traveller from the point of departure to the destination in a safe, practical and convenient manner. Over a million people per month take trans-oceanic flights from Canada to overseas countries and vice versa. The development of an optimized light therapy schedule algorithm for use of Sunnex Biotechnologies' Lo-LIGHT lamp would effectively addresses the widespread circadian rhythm problems that has no practical solution at this time.